<VariationArchive RecordType="classified" VariationID="1073971" VariationName="NC_000009.11:g.(?_140646763)_(140729425_?)del" VariationType="Deletion" Accession="VCV001073971" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-29" DateCreated="2021-05-10" MostRecentSubmission="2021-05-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057402" VariationID="1073971">
      <GeneList>
        <Gene Symbol="EHMT1" FullName="euchromatic histone lysine methyltransferase 1" GeneID="79813" HGNC_ID="HGNC:24650" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137619005" stop="137836127" display_start="137619005" display_stop="137836127" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140513443" stop="140730578" display_start="140513443" display_stop="140730578" Strand="+" />
          </Location>
          <OMIM>607001</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC651337" FullName="uncharacterized LOC651337" GeneID="651337" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137784073" stop="137788406" display_start="137784073" display_stop="137788406" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140679527" stop="140679967" display_start="140679527" display_stop="140679967" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000009.11:g.(?_140646763)_(140729425_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" innerStart="140646763" innerStop="140729425" display_start="140646763" display_stop="140729425" variantLength="82663" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(?_140646763)_(140729425_?)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(?_140646763)_(140729425_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.11:g.(?_140646763)_(140729425_?)del AND Kleefstra syndrome 1" Accession="RCV001387114" Version="1">
        <ClassifiedConditionList TraitSetID="948">
          <ClassifiedCondition DB="MedGen" ID="C0795833">Kleefstra syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-03-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2021-05-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22670141</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 1</ElementValue>
                <XRef ID="MONDO:0027407" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsyÂ / febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</Attribute>
                <XRef ID="NBK47079" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945554</ID>
                <ID Source="BookShelf">NBK47079</ID>
              </Citation>
              <XRef ID="261494" DB="Orphanet" />
              <XRef ID="C0795833" DB="MedGen" />
              <XRef ID="MONDO:0027407" DB="MONDO" />
              <XRef Type="MIM" ID="610253" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3113307" SubmissionDate="2021-01-07" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_024757.4_9_Deletion (exons 7-27)|MedGen:C0795833" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001587649" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22670141</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 7-27 of the EHMT1 gene. The 5' boundary is likely confined to intron 6. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. This variant has not been reported in the literature in individuals with EHMT1-related conditions. This variant disrupts the C-terminus of the EHMT1 protein. Other variant(s) that disrupt this region (p.Ser960Glyfs*7) have been determined to be pathogenic (PMID: 22670141). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EHMT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(?_140646763)_(140729425_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0795833" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3113307" TraitType="Disease" MappingType="XRef" MappingValue="C0795833" MappingRef="MedGen">
        <MedGen CUI="C0795833" Name="Kleefstra syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

